Authors

• Silvia Novello (ORCID: https://orcid.org/0000-0001-7653-9748)
• Jhanelle E. Gray (ORCID: https://orcid.org/0000-0003-1304-7062)
• Luis Paz‐Ares (ORCID: https://orcid.org/0000-0002-1947-3364)
• Paul Schwarzenberger
• Julien Mazières (ORCID: https://orcid.org/0000-0002-5921-7613)
• Delvys Rodríguez‐Abreu (ORCID: https://orcid.org/0000-0003-0506-1366)
• Andrew Robinson (ORCID: https://orcid.org/0000-0003-1152-4275)
• Steven Powell (ORCID: https://orcid.org/0000-0002-5029-0048)
• Jing Yang (ORCID: https://orcid.org/0000-0003-1780-1659)
• Balázs Halmos (ORCID: https://orcid.org/0000-0001-7548-8360)
• Marina Chiara Garassino (ORCID: https://orcid.org/0000-0002-3821-5598)
• Cong Chen (ORCID: https://orcid.org/0000-0003-0875-7473)
• Meihua Wang (ORCID: https://orcid.org/0000-0002-0115-1041)
• Fabricio Souza
• Ying Cheng (ORCID: https://orcid.org/0009-0008-8384-2647)

Institutions

• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• Albert Einstein College of Medicine (US)
• Sanford Health (US)
• Montefiore Medical Center (US)
• Université Toulouse III - Paul Sabatier (FR)
• Hospital Universitario Insular de Gran Canaria (ES)
• Kingston General Hospital (CA)
• Moffitt Cancer Center (US)
• University of Chicago (US)
• Jilin Province Tumor Hospital (CN)
• Hospital Universitario 12 De Octubre (ES)
• Ospedale San Luigi Gonzaga (IT)
• Daiichi Sankyo (United States) (US)

Publication Details

Journal

Oncology and Therapy

Published

2025-06-11

DOI

https://doi.org/10.1007/s40487-025-00350-6

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00